Title
Category
Credits
Event date
Cost
  • PAINWeek
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$899.00
PAINWeek Digital All Acess is an online library of sessions from the PAINWeek Conference that you can watch anytime, anywhere. Plus, every session is certified for credit.It’s great for people who had to miss the meeting, or for those who have attended but couldn't fit every desired session into their schedule.
  • PAINWeek
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$0.00
Treatments targeting calcitonin gene-related peptide (CGRP) effectively treat migraine and have changed our approach to the disorder. This course will review how these medications work and provide updates on their safety and effectiveness. We will particularly focus on differences between monoclonal antibodies and small molecule antagonists against CGRP, acute and preventive treatment, and individualizing therapy for each patient.This activity is supported by an educational grant from GlaxoSmithKline
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
$0.00
How rare is a rare disease?While the number of people affected by an individual rare disease may be small, the total number of people with a rare diseases—an estimated 25 to 30 million in the United States—is enormous!This BRAINWeek live, virtual stemINAR has been developed for specialists and frontline practitioners treating CNS disorders associated with rare or common diseases.
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
$0.00
The catastrophic health effects of the coronavirus pandemic are well established, as illustrated by the more than 32 million known cases and over 570,000 COVID-19-related deaths in the United States to date. What has also become more apparent is the immense psychological impact.
  • CMHC
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
$0.00
The 2022 CMHC Spring recorded sessions highlight the latest updates in CKD, heart failure, hypertension, type 2 diabetes, dyslipidemia, lifestyle management, obesity, and cardiovascular health, as well as translate cutting-edge medical research into practical, clinical strategies for preventing, delaying, and managing cardio-renal-metabolic disorders.
  • LivDerm
  • TME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
$0.00
Melanoma can be a life-threatening condition if left untreated. Patients with skin of color often face delays in diagnosis and treatment initiation in melanoma care. These disparities point to the need for increased awareness and education on melanoma risk and identification for clinicians and patients. Immunotherapies as mono and combination therapeutic regimens have become the gold standard in melanoma management.
  • PAINWeek
  • AAFP
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$499.00
The enormity of CNS-related conditions poses an immense burden to public health. In 2022, there remain significant knowledge gaps among clinicians treating neurologic and psychiatric disorders. Conditions such as dementia, epilepsy, migraine, MS, and stroke require a more inclusive approach to continuing medical education.The BRAINWeek 2022 Digital All Access agenda has been crafted to address the most frequently diagnosed conditions encountered in clinical practice, with an emphasis on collaborative care among specialists and frontline practitioners. 
  • CMHC
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
$0.00
Aortic stenosis (AS) is a fatal disease if not treated promptly, especially in the older population. There is a need of multidisciplinary team approach for the comprehensive diagnosis, staging, risk stratification and treatment involving patient preferences, in order to optimize the management of this insidious disease. Studies have suggested that TAVR can be used as an alternative for SVAR in high risk as well as low risk patients with severe AS. Additionally, guidelines have underlined the benefits of TAVR with many terms and conditions.
  • PAINWeek
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$1,500.00
  • PAINWeek
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$1,500.00

Pages